- Research works
- 116 ▲ 72% vs 2013–17
- Citations
- 2.8k 24.0 per fractional work
- Top-10% rate
- 13.1% record average 16.5%
- Open access
- 45% world 28%
Not ranked overall: Eli Lilly (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.9×. Every wedge is a field page.
- Immunology and Microbiology 9.9×
- Veterinary 5.2×
- Medicine 3.5×
- Biochemistry, Genetics and Molecular Biology 2.3×
- Economics, Econometrics and Finance 1.3×
- Physics and Astronomy 0.9×
- Agricultural and Biological Sciences 0.7×
- Neuroscience 0.5×
- Decision Sciences 0.1×
- Environmental Science 0.1×
- Health Professions 0.0×
- Engineering 0.0×
- Social Sciences 0.0×
Which keywords describe research at Eli Lilly (Italy)?
By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Depression, Breast Cancer, Metabolic Syndrome, Clinical Guidelines, Biomarkers and Cardiovascular Disease.
- Treatment Guidelines
- Insulin-like Growth Factors
- Hypoglycemia
- Type 1 Diabetes
- Neuroendocrine Control
- Cognitive Function
- Complications
- Dementia
- Aging
- Glucose Control
- Heart Failure
- Neurological Disorders
- Cardiovascular Risk
- Clinical Trials
- Type 2 Diabetes
- Chemotherapy
- Clinical Guidelines
- Metabolic Syndrome
- Breast Cancer
- Insulin Therapy
- Glycemic Control
- Depression
- Inflammation
- Cardiovascular Disease
- Biomarkers
- Diabetes
- Cancer
- Neuroimaging
- Alzheimer's Disease
- Estrogen
- Cardiovascular Outcomes
- Growth Hormone
- Caregiver Burden
- Cognitive Decline
- Mild Cognitive Impairment
- Prognostic Factors
- Targeted Therapy
- Continuous Glucose Monitoring
- IGF-1
- Synaptic Plasticity
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycemic Control9▲ 57×4 topics
- Insulin Therapy9▲ 69×3 topics
- Depression8▲ 8.8×12 topics
- Breast Cancer8▲ 23×8 topics
- Inflammation7▲ 2.7×19 topics
- Metabolic Syndrome7▲ 7.4×12 topics
- Cardiovascular Disease7▲ 5.4×7 topics
- Clinical Guidelines7▲ 19×5 topics
- Biomarkers6▲ 8.3×7 topics
- Chemotherapy6▲ 7.2×17 topics
- Diabetes6▲ 9.8×8 topics
- Type 2 Diabetes6▲ 26×5 topics
- Cancer5▲ 3.2×10 topics
- Clinical Trials5▲ 7.3×10 topics
- Neuroimaging5▲ 16×5 topics
- Cardiovascular Risk5▲ 12×6 topics
- Alzheimer's Disease5▲ 15×6 topics
- Neurological Disorders4▲ 5.6×11 topics
- Estrogen4▲ 49×2 topics
- Heart Failure4▲ 8.2×4 topics
- Cardiovascular Outcomes4▲ 83×1 topic
- Glucose Control4▲ 83×1 topic
- Growth Hormone4▲ 41×2 topics
- Aging4▲ 6.3×3 topics
- Caregiver Burden4▲ 39×2 topics
- Dementia4▲ 45×2 topics
- Cognitive Decline4▲ 29×1 topic
- Complications4▲ 6.1×4 topics
- Mild Cognitive Impairment4▲ 50×1 topic
- Cognitive Function4▲ 15×5 topics
- Prognostic Factors3▲ 6.5×6 topics
- Neuroendocrine Control3▲ 43×2 topics
- Targeted Therapy3▲ 13×3 topics
- Type 1 Diabetes3▲ 30×2 topics
- Continuous Glucose Monitoring3▲ 58×1 topic
- Hypoglycemia3▲ 58×1 topic
- IGF-13▲ 57×1 topic
- Insulin-like Growth Factors3▲ 57×1 topic
- Synaptic Plasticity3▲ 8.5×3 topics
- Treatment Guidelines3▲ 12×2 topics
Which research topics does Eli Lilly (Italy) publish most on?
By volume in 2022–2025: Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies and Breast Cancer Treatment Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Psoriasis: Treatment and Pathogenesis Immunology 2 works
- 2 Spondyloarthritis Studies and Treatments Rheumatology 1 works
- 3 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
- 4 Breast Cancer Treatment Studies Cancer Research 1 works
- 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 6 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 7 Dermatology and Skin Diseases Dermatology 0 works
- 8 Migraine and Headache Studies Psychiatry and Mental health 0 works
- 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Eli Lilly (Italy)'s research output changed?
Output in 2018–2022 was 72% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Sesto Fiorentino
- Istituto Nazionale di Fisica Nucleare, Sezione di Firenze
- Nello Carrara Institute of Applied Physics
- Institute for the Chemistry of OrganoMetallic Compounds
- Interuniversity Consortium for Magnetic Resonance
- Consorzio Interuniversitario per lo Sviluppo dei Sistemi a Grande Interfase
- Thales (Italy)
- Istituto Nazionale di Fisica Nucleare, Laboratorio di Tecniche Nucleari per l'Ambiente e i Beni Culturali
- Giotto Biotech (Italy)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.